HIDRADENITIS SUPPURATIVA
Clinical trials for HIDRADENITIS SUPPURATIVA explained in plain language.
Never miss a new study
Get alerted when new HIDRADENITIS SUPPURATIVA trials appear
Sign up with your email to follow new studies for HIDRADENITIS SUPPURATIVA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise for controlling painful skin condition in long-term trial
Disease control Not yet recruitingThis phase 3 study tests the long-term safety and effectiveness of remibrutinib, an oral drug, in 710 adults with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition causing painful abscesses. Participants have already completed a prior remibrutinib study. …
Matched conditions: HIDRADENITIS SUPPURATIVA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for painful skin condition: experimental drug LAD328 enters phase 2 trial
Symptom relief Not yet recruitingThis study tests whether the experimental drug LAD328 can reduce symptoms of hidradenitis suppurativa, a chronic skin condition causing painful lumps. About 50 adults with moderate-to-severe disease will receive either LAD328 or a placebo. The main goal is to see if the drug lead…
Matched conditions: HIDRADENITIS SUPPURATIVA
Phase: PHASE2 • Sponsor: Almirall, S.A. • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Heart hope for HS patients: drug may slow artery plaque
Knowledge-focused Not yet recruitingThis study follows 34 adults with moderate-to-severe hidradenitis suppurativa (HS) who are taking secukinumab as part of their routine care. Researchers will use a special CT scan to check if the drug affects the buildup of plaque in the heart arteries over 12 months. The goal is…
Matched conditions: HIDRADENITIS SUPPURATIVA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC
-
Italian skin disease registry aims to map treatment journeys for 20,000 patients
Knowledge-focused Not yet recruitingThis study will collect existing medical records from about 20,000 people aged 12 and older in Italy who have one of five inflammatory skin conditions: psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa. Researchers want to describe who gets thes…
Matched conditions: HIDRADENITIS SUPPURATIVA
Sponsor: Fondazione ISIDE • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Pregnancy hormones may unlock secrets of skin inflammation
Knowledge-focused Not yet recruitingThis study looks at how sex hormones, especially during pregnancy, change the immune cells in the skin. Researchers will compare pregnant women, non-pregnant women, and men, both with and without a skin condition called hidradenitis suppurativa. The goal is to understand how horm…
Matched conditions: HIDRADENITIS SUPPURATIVA
Sponsor: Institut Pasteur • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC